A Phoenix company is now offering a blood test for early detection of breast cancer in Arizona patients. Read the rest of this entry »

Swiss pharmaceutical giant Roche reported Wednesday a better-than-expected 2007 net profit of 11.4 billion Swiss francs (10.4 billion dollars, 7.1 billion euros), boosted by cancer drug sales. Read the rest of this entry »

High levels of a protein called Ki-67 are associated with poor prognosis in women with early-stage breast cancer, but this protein may not be useful in identifying patients who would benefit from additional chemotherapy, an Italian study suggests. Read the rest of this entry »

Researchers involved in an international study have reported that the combination of Omnitarg and Herceptin has significant activity in women with HER2-positive breast cancer who progressed on Herceptin alone. Read the rest of this entry »

According to an article recently published in the Journal of the National Cancer Institute, whether or not a woman with early breast cancer receives radiation therapy may be determined by certain characteristics of her surgeon. Read the rest of this entry »

A medical imager that detects and guides the biopsy of breast cancer lesions can spot tumors half the size detected by current imagers, a U.S. study found. Read the rest of this entry »

Women who live in Chicago’s gentrifying neighborhoods are more apt to receive a late diagnosis of breast cancer than women who live in poverty-stricken neighborhoods, University of Illinois at Chicago researchers have found. Read the rest of this entry »

A new study may explain why women with a mutation in the BRCA1 gene face up to an 85 percent lifetime risk of breast cancer. Read the rest of this entry »

Patients who received panitumumab (Vectibix) plus FOLFOX or FOLFIRI had a faster progression of metastatic colorectal cancer and were more likely to experience severe toxicities. Read the rest of this entry »

Scientists have discovered how low levels of a protein hormone found in body fat, plays a crucial role in tumour growth and spread. Their findings are published in a paper in the British Journal of Cancer. Read the rest of this entry »

Provista Life Sciences LLC, a diagnostic development and commercialization company based in Phoenix, on Tuesday announced the availability of its blood test for early detection of breast cancer in Arizona patients. Read the rest of this entry »

Peregrine Pharmaceuticals has begun patient screening in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with docetaxel in patients with advanced breast cancer. Read the rest of this entry »

German drugmaker Wilex will conduct a Phase II trial with WX-671 in combination with the chemotherapeutic agent Xeloda in patients with HER2-receptor negative metastatic breast cancer. Read the rest of this entry »

A woman’s personality doesn’t affect her odds of developing breast cancer, Dutch researchers report. Read the rest of this entry »

Pathology reports offer a fairly accurate alternative to repeated testing in a central laboratory for determining estrogen receptor status in large epidemiologic studies of women with breast cancer. Read the rest of this entry »

News for the Cure - Breast Screening Technologies

Suspicious breast mass? Learn the importance of re-screening during the diagnostic process and the benefits of new imaging technologies.

News for the Cure - Breast Screening Technologies

There is a broad variation in the risk of developing breast cancer among people who carry the BRCA1 and BRCA2 gene mutation, according to a new article.
Read the rest of this entry »

Roche Holding AG (ROG.VX: Quote, Profile, Research), Europe’s biggest drugmaker, is expected to post a 20-percent rise in annual profit despite growing threats to the sector from tougher regulations, generic competition and patent exposure.
Read the rest of this entry »

IPSOGEN SAS has announced the signature of a license agreement with Universite Libre de Bruxelles (ULB), Belgium for the worldwide and exclusive rights on the Genomic Grade™.
Read the rest of this entry »

As an accomplished and active musician, accounting lecturer, student adviser, wife and mother of two young boys, Cynthia Turner didn’t really have time to write a book.But after surviving breast cancer, the 39-year-old Champaign woman said she had a promise to keep.

Read the rest of this entry »

 The Munich-based biopharmaceutical company Wilex AG (ISIN DE0006614720 / Frankfurt Stock Exchange / Prime Standard) today announced that the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug application (IND) for a clinical Phase II trial with its drug candidate WX-671.

Read the rest of this entry »

A high school basketball player expanded North Carolina State University women’s basketball coach Kay Yow’s game plan to beat breast cancer. Read the rest of this entry »

The Sharon Ewing Walker Breast Health Center at Tallahassee Memorial HealthCare presents “What is Breast Cancer” by the Breast Cancer Patient Navigator Team, presenting a program about Breast Cancer, Triple-Touch II breast self-exams, Newly Diagnosed Breast Cancer Counseling, Genetic Counseling, Image Recovery, Breast Procedures, Rehabilitation and Lymphedema Management after Mastectomy, and American Cancer Society Signature Programs. Read the rest of this entry »

Report Buyer, the online destination for business intelligence for major industry sectors, has added a report which finds that an FDA advisory panel has said that Genentech/Roche’s Avastin® should not receive FDA approval for metastatic breast cancer.
Read the rest of this entry »

While a family history of breast cancer or a genetic mutation can’t be controlled, you can control or change some risk factors associated with this disease. And even with those risks that can’t be reduced, understanding them can help you take steps to detect the disease early, at a highly treatable stage. Read the rest of this entry »

Although chemotherapy is recommended for many women with early-stage breast cancer, the benefit of chemotherapy varies. Identifying in advance those women who are most likely to benefit from chemotherapy may allow for more-individualized treatment. This would allow women who are unlikely to benefit from chemotherapy to avoid the toxic effects of treatment. Read the rest of this entry »

AUSTRALIAN women could be tested for breast cancer through the strands of their hair using a new screening method later this year. Read the rest of this entry »

This study is currently recruiting participants.
Verified by Biogen Idec, December 2007

Purpose

The goal of this clinical research study is to study the drug CNF2024 as a single agent or in combination with trastuzumab in patients with advanced breast cancer and to: Read the rest of this entry »

This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), December 2007
Purpose

RATIONALE: Venlafaxine may be effective in relieving hot flashes caused by hormone therapy. Giving venlafaxine with zolpidem (a sleeping pill) may improve sleep and quality of life in women who are receiving hormone therapy for treatment or prevention of breast cancer. Read the rest of this entry »

This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), April 2007

Purpose

RATIONALE: Drugs used in chemotherapy, such as methotrexate, cyclophosphamide, and liposomal doxorubicin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving chemotherapy after surgery may kill any tumor cells that remain after surgery. It is not yet known whether giving liposomal doxorubicin after surgery is more effective than observation or cyclophosphamide and methotrexate in treating breast cancer.

PURPOSE: This randomized phase III trial is studying liposomal doxorubicin to see how well it works compared with observation or cyclophosphamide and methotrexate in treating older women who have undergone surgery for breast cancer.

http://clinicaltrials.gov/ct2/show/NCT00296010?term=breast+cancer&rank=8